expand_moreexpand_less
Aeon
Al Jazeera
América Economía
Blitz
Buenos Aires Herald
Deutsche Welle
Dnevnik
E-International
Haaretz
Il Manifesto Global
Japan Today
Khaama PressMiddle East Monitor
New Eastern OutlookNikkei Asian ReviewOped Column
Pravda.sk
Project Syndicate
Psychology Today
qolumnistRT.comSME.sk
South China Morning PostThe Asahi ShimbunThe Japan NewsThe Japan Times
The Korea TimesThe Times of IsraelThe Times of Israel (Blogs)TRT WorldVečer
العين الإخبارية 
Toi Staff
Sabine SterkEmanuel FabianAgenciesLazar BermanLuke TressJacob MagidReutersJessica SteinbergRossella TercatinSue SurkesRev Dr Munther Isaac
Penny S. TeePeter BaumThe Asahi ShimbunZev StubThe Japan News EditorialJeremy SharonAeon VideoAndrew LapinGrace GilsonNoam LehmannJasim Al-AzzawiStav Levaton
Gideon LevyAnna Ciaunica
Waka IkedaDiana BletterSam SokolTajul IslamThe Yomiuri ShimbunVeronika Rupnik ŽenkoLeon KraiemMojca Furlan - RusAlexander Batthyány Ph.dAriela KarmelM A Hossain
Grant Arthur GochinLucas LeirozSalah Uddin Shoaib ChoudhuryPhilissa CramerFrank J. Ninivaggi M.dSherry ChanCraig OgdenCharlie SummersSuraiyya AzizAndrea BranchiAbul Quashem JoarderElinor Greenberg Ph.d
Rachel Marsden
|
 |
Some popular weight loss drugs may lower the risk of dementia and stroke for patients with Type 2 diabetes and obesity, new research published in JAMA Network suggests.
Patients taking © The Hill
visit website 
login
who are we?
contact us
qosheapp
